Recent progress on the diagnosis of 2019 Novel Coronavirus.

Corona Virus Disease 2019 (COVID-19) antibody clustered regularly interspaced short palindromic repeats (CRISPR) detection real-time RT-PCR reverse transcription loop-mediated isothermal amplification (RT-LAMP) severe acute respiratory syndrome coronavirus 2 (2019 Novel Coronavirus SARS-CoV-2)

Journal

Transboundary and emerging diseases
ISSN: 1865-1682
Titre abrégé: Transbound Emerg Dis
Pays: Germany
ID NLM: 101319538

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 14 03 2020
revised: 03 05 2020
accepted: 04 05 2020
pubmed: 13 5 2020
medline: 15 7 2020
entrez: 13 5 2020
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. Therefore, convenient, timely and accurate detection of SARS-CoV-2 is urgently needed. Here, we review the types, characteristics and shortcomings of various detection methods, as well as perspectives for the SARS-CoV-2 diagnosis. Clinically, nucleic acid-based methods are sensitive but prone to false-positive. The antibody-based method has slightly lower sensitivity but higher accuracy. Therefore, it is suggested to combine the two methods to improve the detection accuracy of COVID-19.

Identifiants

pubmed: 32395897
doi: 10.1111/tbed.13620
pmc: PMC7272792
doi:

Substances chimiques

Antibodies, Viral 0
COVID-19 Vaccines 0
Covid-19 aAPC vaccine 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1485-1491

Subventions

Organisme : National Natural Science Foundation of China
ID : 31772747
Organisme : Science and Technology Research Program during the 13th Five-Year Plan Period of Jilin Educational Committee
ID : JJKH20190172KJ
Organisme : National Key Research and Development Program of China
ID : 2017YFD0500103

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2020 Blackwell Verlag GmbH.

Références

Trends Mol Med. 2020 May;26(5):483-495
pubmed: 32359479
J Infect Dis. 2020 Jun 29;222(2):189-193
pubmed: 32382737
J Clin Microbiol. 2020 Apr 23;58(5):
pubmed: 32132196
Zhonghua Yi Xue Za Zhi. 2020 Apr 7;100(13):961-964
pubmed: 32077662
Front Med (Lausanne). 2021 Apr 12;8:569266
pubmed: 33912572
J Med Virol. 2020 Sep;92(9):1518-1524
pubmed: 32104917
Infect Genet Evol. 2020 Aug;82:104285
pubmed: 32169673
Infect Genet Evol. 2020 Apr;79:104212
pubmed: 32004758
Clin Infect Dis. 2020 Jul 28;71(15):841-843
pubmed: 32047895
Zhonghua Yi Xue Za Zhi. 2020 Feb 19;100(0):E008
pubmed: 32072795
Clin Chem Lab Med. 2020 Jun 25;58(7):1089-1094
pubmed: 32301745
Vet Ital. 2020 Apr 21;56(1):7-8
pubmed: 32315124
Methods. 2022 Jul;203:431-446
pubmed: 33839288
Travel Med Infect Dis. 2020 Sep-Oct;37:101673
pubmed: 32311437
Transbound Emerg Dis. 2020 Jul;67(4):1485-1491
pubmed: 32395897
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2271-2277
pubmed: 32681308
J Med Virol. 2020 Jun;92(6):680-682
pubmed: 32124995
Wellcome Open Res. 2020 Jun 11;5:139
pubmed: 33748431
Microb Biotechnol. 2020 Jul;13(4):950-961
pubmed: 32333644
Nat Protoc. 2019 Oct;14(10):2986-3012
pubmed: 31548639
Clin Infect Dis. 2020 Nov 5;71(8):1937-1942
pubmed: 32301997
Clin Infect Dis. 2020 Jul 28;71(15):778-785
pubmed: 32198501
Emerg Microbes Infect. 2020 Dec;9(1):998-1007
pubmed: 32306853
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):139-144
pubmed: 32057211
Clin Microbiol Infect. 2020 Jun;26(6):773-779
pubmed: 32276116
Science. 2020 May 29;368(6494):1016-1020
pubmed: 32269068
Clin Infect Dis. 2020 Nov 5;71(8):1930-1934
pubmed: 32306047
Transbound Emerg Dis. 2020 Jul;67(4):1745-1749
pubmed: 32303108
Sci China Life Sci. 2020 May;63(5):777-780
pubmed: 32270436
Science. 2018 Apr 27;360(6387):444-448
pubmed: 29700266
J Infect. 2020 Jul;81(1):e28-e32
pubmed: 32283141
Clin Chem. 2020 Apr 1;66(4):549-555
pubmed: 32031583

Auteurs

Chun Li (C)

The Chinese Peoples' Liberation Army 964 Hospital, Changchun, China.

Linzhu Ren (L)

College of Animal Sciences, Jilin University, Changchun, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH